Qubigen (@qubigen) header
Qubigen (@qubigen) profile picture

Intelligent Drug Design. A global federated AI system and computational toolbox for designing novel targeted medicines

Joined November 2024
Photo by Qubigen (@qubigen)Photo by Qubigen (@qubigen)Photo by Qubigen (@qubigen)Photo by Qubigen (@qubigen)Photo by Qubigen (@qubigen)Photo by Qubigen (@qubigen)Photo by Qubigen (@qubigen)Photo by Qubigen (@qubigen)Photo by Qubigen (@qubigen)Photo by Qubigen (@qubigen)
Qubigen won Gold in Medical at the 2026 AFR BOSS Most Innovative Companies Awards. While the big agentic AI and frontier lab deals (Xairaโ€™s X-Scientist, OpenAIโ€™s Orchestra Bio acquisition, AZโ€“insitro) get the headlines, the hard constraint remains the same: most models still need either public data or private project data that leaves the lab.
2
1
97
Congrats to @DrJMMHall and the @QubigenOps @qubigen team for winning Gold in the AFR Most Innovative Companies 2026 Awards for their novel AI platform which enables AI for drug design without compromising stakeholder privacy or intellectual property. afr.com/life-and-luxury/healโ€ฆ
1
2
2
81
โ€œWinning gold in the Medical category of the Financial Review BOSS Most Innovative Companies awards, Qubigenโ€™s AI tool can learn from a trove of pharmaceutical lab investigations, all without copying or sharing the data.โ€ See link to the full article in the comments below ๐Ÿ‘‡
1
1
1
67
๐Ÿšจ ๐Ÿšจ On Wednesday Night, @qubigen was named the Gold winner in the Medical category of The Australian Financial Review AFR BOSS Most Innovative Companies Awards, taking out the top spot of this National competition! ๐Ÿ† This recognition reflects the groundbreaking work our team is doing to pioneer decentralised intelligence in drug discovery: building a platform that allows research labs to learn from their own high-value results without ever compromising, copying, or sharing raw data. A huge congratulations ๐Ÿฅ‚ and thank you to our all-star team who made this possible: Sonya Diakiw (CSO), A/Prof Jun Zeng FRACI (CIO), Andrew Murphy (CTO), David Brooks (Operations Manager), Dr Tuc Van Nguyen (Senior Machine Learning Engineer), and Joshua Spender (Senior Software Engineer). Special thanks to our board of directors for their continued support and backing, SYNthesis BioVentures, Prof. Andrew Wilks , Dr Amir Zalcenstein, Dr Fabio Turatti, James Roche, Chair Dr Michelle Perugini and our Corp Sec Rosemarie Singson. Thank you to our advisors Matt Oristano, Trevor Thompson, Eric Hayes, and finally, to all the research and commercial partners who have worked with us and continue to collaborate with us on live projects.
2
2
2
151
Federated AI Engines for drug design enable secure collaboration, transcending institutional data firewalls. Qubigen's FedAIDD can leverage global data without actually moving or seeing it, to build the most intelligent, secure, disease-agnostic AI engines in drug design.
1
1
4
88
. @qubigen is heading to San Francisco for J.P. Morgan Healthcare Week 2026 (11โ€“15 January)! ๐Ÿ‡บ๐Ÿ‡ธ ๐Ÿ‡ฆ๐Ÿ‡บ๐Ÿจ Proud to be part of the Australian Biotech Delegation, supported by Global Victoria. Weโ€™ll be actively partnering at BIO One-on-One, ABD Capital Connect sessions, and around Union Square. Our Federated AI/ML platform is already accelerating drug design for pharma and CRO partners, collapsing hit-to-lead from years to weeks, securely and at fraction of the cost. If youโ€™re attending and interested in AI-enabled drug design or Series A discussions, letโ€™s connect! Reach me via BIO Partnering, ABD, or DM here. Excited to build new bridges Down Under in the Bay Area.
2
2
4
217
Weโ€™re excited to introduce the next group of Xtalks Featured Community Members, celebrating the people advancing life sciences across pharma, biotech, medtech, healthcare and beyond. Our newest members include: ยท Christopher Missling, PhD, President & CEO, Anavex Life Sciences ยท Jonathan Hall, PhD, Founder & CEO, Qubigen ยท Mark Franklin, Manager, Curation, DrugBank ยท Petra Elischer, Head of Quality and Regulatory Affairs, Hart Biologicals Limited ยท Rebecca Starkie, Consultant, Civia Health Meet them all at buff.ly/LSA0I1d and learn how to apply or nominate a colleague at buff.ly/LdsbLY7. #LifeSciences #Biotech #Pharma #MedTech #ClinicalResearch #XtalksCommunity #Leadership
2
1
3
453
Qubigen retweeted
Qubigen is proud to announce that Dr Jun Zeng, Co-Founder and Chief Information Officer, has been elected as a Fellow of the Royal Australian Chemical Instituteย (FRACI), the highest professional membership grade awarded by the Institute. qubigen.com/post/qubigen-co-โ€ฆ
2
1
3
101
๐Ÿ”‘Qubigen is helping to crack the world's toughest diseases by fostering a collaborative federated data approach for new medicines that no single company could develop on their own. โ‰๏ธWhat's a specific diseases that you would love to see cured in our life time?
1
4
80
๐ŸฆพWe're looking to #SummerSlam hard into difficult 'undruggable' diseases. ๐Ÿง Qubigenโ€™s Federated AI and quantum chemistry platform unlocks global drug design data without exposing its secrets, enabling partners to collaborate on groundbreaking medicines for the toughest diseases. Which diseases is worthy of being punched up nextโ‰๏ธ๐Ÿ†
1
3
66
Good reasoning engines need quality data to train on. With drug design, generic public data wonโ€™t cut it. The best data are locked behind institutional firewalls and Big Pharma ๐Ÿ” Federated AI ๐Ÿค– could be the solution to unlock medicines unachievable in a single company
We released two open-weight reasoning modelsโ€”gpt-oss-120b and gpt-oss-20bโ€”under an Apache 2.0 license. Developed with open-source community feedback, these models deliver meaningful advancements in both reasoning capabilities & safety. openai.com/index/introducingโ€ฆ
2
1
1
3
209
At Qubigen, we're rewriting the rules of how new medicnes are discovered, and weโ€™re inviting the world to join us. ๐Ÿ˜ฎImagine slashing drug design timelines from years to just weeks - tackling the toughest diseases with a global, collaborative approachโ€”without ever compromising sensitive data. Weโ€™re making it happen with our cutting-edge Federated AI and quantum chemistry platform. โ€ผ๏ธHereโ€™s the problem: Big Pharmaโ€™s best data can hold the key to breakthroughs, but it sits locked behind proprietary firewalls. Traditional AI models like those built on public data (sorry, AlphaFold) canโ€™t touch it. Outdated, limited datasets just donโ€™t cut it for the next generation of medicines. ๐Ÿง ๐Ÿค–Enter Qubigen. Our patented Federated AI technology lets research institutes, biotechs, and pharma giants collaborate securely across the globe, analyzing proprietary datasets without exposing background IP. Pair that with our GPU-accelerated virtual screening and quantum chemistry tools, and weโ€™re not just designing drugs fasterโ€”weโ€™re creating the largest, most intelligent, disease-agnostic computational toolbox for AI-driven drug design ever. ๐Ÿงช
3
1
4
81
๐Ÿš€Groundbreaking open-source paper alert! Qubigen's Federated AI is a game-changer for training AI on global, decentralized data securely! ๐Ÿ”‘Key points: - Privacy-first: No transfer of external needed. - Matches centralized AI accuracy, and in cases of dirty data, can exceed it! -Outperforms traditional methods on messy healthcare data. -Clustering optimization slashes model transfer costs. Check it out: nature.com/articles/s41598-0โ€ฆ
2
1
6
129
Replying to @DrJMMHall
Qubigen's got the keys to Big Pharma's vault. Game changer! ๐Ÿ’ฅ
3
1
1
3
159
๐Ÿšจ โ€ผ๏ธ Reminder! We could see a massive shift in AI. GROK 4 can do great as a reasoning engine, and on generic, public data sources. But that simply wonโ€™t work for designing new medicines - as the relevant data is behind institutional firewalls that only Qubigen could accessโ€ฆ
The GPT of Biopharma โ€ฆ uniquely enabled by Federated AI Unlike ChatGPT, Qubigenโ€™s Federated AI leverages the best data, which remains securely locked in Big Pharma ๐Ÿ”. Slashes drug design from years to weeks and unlocks collaborative breakthroughs for trillion-dollar disruption
6
2
1
16
3,195
Qubigen retweeted
Replying to @DrJMMHall
Qubigen's federated learning enables collaborative AI training on decentralized, private datasets without data sharing, preserving IP and privacy. This gives it an edge in drug design by accessing exclusive pharma data for more accurate, novel molecule generationโ€”unlike centralized LLMs like Grok or ChatGPT, which rely on public data and lack real-time proprietary integration. Scalable and cost-effective, it accelerates therapeutics discovery.
Link preview

1
1
1
1,520
๐Ÿš€๐™Œ๐™ช๐™—๐™ž๐™œ๐™š๐™ฃ ๐™ž๐™จ ๐™–๐™˜๐™˜๐™š๐™ก๐™š๐™ง๐™–๐™ฉ๐™ž๐™ฃ๐™œ ๐™ฉ๐™๐™š ๐™›๐™ช๐™ฉ๐™ช๐™ง๐™š ๐™ค๐™› ๐™๐™š๐™™๐™š๐™ง๐™–๐™ฉ๐™š๐™™ ๐˜ผ๐™„ for drug design, and weโ€™re on the hunt for a visionary lead investor to join our journey! Our innovative platform is transforming biotech ๐Ÿงซ, and weโ€™ve already secured strategic pre-seed funding from SYNthesis BioVentures, with a second tranche unlocked ahead of schedule due to groundbreaking results. Be part of a mission to revolutionize precision medicine... ๐™˜๐™ค๐™ก๐™ก๐™–๐™—๐™ค๐™ง๐™–๐™ฉ๐™ž๐™ค๐™ฃ ๐™ฌ๐™ž๐™ฉ๐™๐™ค๐™ช๐™ฉ ๐™ง๐™š๐™ซ๐™š๐™–๐™ก๐™ž๐™ฃ๐™œ ๐™จ๐™š๐™˜๐™ง๐™š๐™ฉ๐™จ Learn more about our progress and connect with us to explore this exciting investment opportunity: โ€ข Qubigen Secures Pre-Seed Investment: shorturl.at/Sk8Bm โ€ข Second Tranche Unlocked Early: shorturl.at/R0l7Y DM us or visit qubigen.com to get involved! #AI #DrugDiscovery #InvestmentOpportunity #HealthcareInnovation #Science
1
2
2
6
996
Researchers from the Parkinsonโ€™s Disease Research Centre at WEHI & the National Drug Discovery Centre have discovered a molecule that blocks cell death, a finding that could lead to next-generation drugs for neurogenerative condition. wehi.edu.au/news/cell-death-โ€ฆ
4
3
9
819
A perfect reason for AI to inherit even more exciting capital activity in the market - as people strive for cheaper, faster and more effective drug development methods
1
169